Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-02-28 @ 6:27 AM
Study NCT ID:
NCT05411133
Status:
RECRUITING
Last Update Posted:
2025-09-04
First Post:
2022-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Sponsor:
Arbele Pty Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastrointestinal Cancer | View |
| None | Cholangiocarcinoma | View |
| None | Liver Cancer | View |
| None | Colorectal Adenocarcinoma | View |
| None | Pancreatic Cancer | View |
| None | Gastric Cancer | View |
| None | Esophageal Adenocarcinoma | View |
| None | Gastroesophageal Junction | View |
| None | Gastrointestinal Neuroendocrine Tumors | View |
Keywords: